Updates are available Correction dated 2021-09-21
Click to view Correction: https://doi.org/10.1038/s41380-021-01289-6
-
Authors
Urresti, Jorge
Zhang, Pan
Moran-Losada, Patricia
Yu, Nam-Kyung
Negraes, Priscilla D.
Trujillo, Cleber A.
Antaki, Danny
Amar, Megha http://orcid.org/0000-0003-4791-8188
Chau, Kevin http://orcid.org/0000-0002-4903-6544
Pramod, Akula Bala
Diedrich, Jolene
Tejwani, Leon
Romero, Sarah
Sebat, Jonathan http://orcid.org/0000-0002-9087-526X
Yates III, John R. http://orcid.org/0000-0001-5267-1672
Muotri, Alysson R. http://orcid.org/0000-0003-0867-2875
Iakoucheva, Lilia M. http://orcid.org/0000-0002-4542-5219
- License Information
-
More Information
Article History
Received: 19 October 2020
Revised: 12 July 2021
Accepted: 20 July 2021
First Online: 26 August 2021
Change Date: 21 September 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41380-021-01289-6
Competing interests
: Dr. Muotri is a co-founder and has equity interest in TISMOO, a company dedicated to genetic analysis and human brain organogenesis, focusing on therapeutic applications customized for autism spectrum disorders and other neurological disorders origin genetics. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies.
